Can breastfeeding reduce multiple sclerosis relapses?

Feb 19, 2009

Women who have multiple sclerosis may reduce their risk of relapses after pregnancy if they breastfeed their babies, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 to May 2, 2009.

For the study, researchers followed 32 pregnant women with MS and 29 pregnant women without MS during each trimester and up to a year after they gave birth. The women were interviewed about their breastfeeding and menstrual period history.

A total of 52 percent of the women with MS did not breastfeed or began supplemental formula feedings within two months of giving birth. Of those, 87 percent had a relapse after pregnancy compared to 36 percent of women with MS who breastfed exclusively for at least two months after pregnancy.

Sixty percent of the women reported their main reason for not breastfeeding exclusively was to start taking MS treatments again. Women who began taking MS treatments within the first two months after giving birth had significantly higher risk of suffering a relapse than women with MS who did not start taking medications early, regardless of whether they breastfed. Those who breastfed exclusively got their menstrual periods back later than the women who did not breastfeed or began early supplemental feedings.

"Our findings call into question the benefit of choosing not to breastfeed or stopping breastfeeding early in order to start taking MS therapies," said study author Annette Langer-Gould, MD, PhD, of Stanford University in California, and a member of the American Academy of Neurology. "Larger studies need to be done on whether women should delay taking MS medications in order to breastfeed."

Source: American Academy of Neurology

Explore further: New research demonstrates benefits of national and international device registries

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.